Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Clinical trial NCT00003338 · UNKNOWN
Trial details
- NCT number
- NCT00003338
- Sponsor
- Gilead Sciences
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.